medigraphic.com
ISSN 1029-3019 (Electronic)

2013, Number 03

<< Back Next >>

MediSan 2013; 17 (03)

Characterization of patients with soft tissue sarcomas. A study of 12 years

Infante CMC, Jaén IL, González CME, Lubín GA

Language: Spanish
References: 19
Page: 491-498
PDF size: 51.89 Kb.


ABSTRACT

A longitudinal, descriptive and cross-sectional study was conducted in 89 patients with soft tissue sarcomas, attended in "Conrado Benítez García" Provincial Teaching Oncology Hospital of Santiago de Cuba, from January 2000 to December 2011, after being referred primarily from other care centers (where they were diagnosed with and operated), to be assessed and treated by a multidisciplinary team, with the purpose of characterizing them and thus applying different diagnostic and therapeutic modalities in them. A higher frequency of the disease at younger ages, of fibrosarcoma and fibrous histiocytoma as tissular varieties, and location in the lower limbs was found in the case material. It was stressed that early diagnosis is crucial, as well as the treatment of choice consisting in non-mutilating resection combined with adjuvant treatment or not. Most patients were reoperated and diagnosed in stage II of the disease, worsening the prognosis and indicating the existence of incomplete procedures in the therapeutic process that conspire to harm the survival of patients.


REFERENCES

  1. Pérez Oramas H, Del Sol Castañeda O. Tumores de las partes blandas superficiales. En: García Gutiérrez A, Pardo Gómez G. Cirugía. La Habana: Editorial Ciencias Médicas; 2007: T 4.

  2. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000; 50(1): 7-33.

  3. Deenik W, Mooi WJ, Rutgers EJ, Peterse JL, Hart AA, Kroon BB. Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases. Cancer. 1999; 86(6): 969-75.

  4. Frascella E, Toffolatti L, Rosolen A. Normal and rearranged PAX3 expression in human rhabdomyosarcoma. Cancer Genet Cytogenet. 1998; 102(2): 104-9.

  5. Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti- PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol. 1989; 134(4): 733-9.

  6. Gustafson P, Ferno M, Akerman M, Baldetorp B, WiIlen H, Killander D, et al. Flow cytometric S-phase fraction in soft-tissue sarcoma: prognostic importance analysed in 160 patients. Br J Cancer. 1997; 75(1): 94-100.

  7. Tadashi K. Bone and soft tissue tumors. NIRS-M (Natl Inst Radiol Sci). 2003; (168): 31-4.

  8. Heslin MJ, Lewis JJ, Nadler E, Newman E, Woodruff JM, Casper ES, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol. 1997; 15(8): 2832-9.

  9. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med. 2001; 344(14): 1052-6.

  10. Trovik CS, Bauer HC, Brosjö O, Skoog L, Söderlund V. Fine needle aspiration (FNA) cytology in the diagnosis of recurrent soft tissue sarcoma. Cytopathology. 1998; 9(5): 320-8.

  11. Oosterom AT, Judson I, Verweij J. STI 157, an active drug in metastatic gastro intestinal stromal tumors (GIST), an EORTC phase I study. Proc Annu Meet Am Soc Clin Oncol. 2001; 20: 1.

  12. Wunder JS, Healey JH, Davis AM, Brennan MF. A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer. 2000; 88(12): 2721-30.

  13. Bakke OM, Carné Cladellas X, García Alonso F. Ensayos Clínicos con Medicamentos. Fundamentos Básicos Metodología y Práctica. Barcelona: Doyma; 1994. p. 13-4.

  14. Cuba. Ministerio de Salud Pública. Buenas prácticas reguladoras cubanas. La Habana: CECMED; 2002.

  15. Department of Health and Human Service. International Conference on Harmonisation; Guidance on General Considerations for Clinical Trials. Federal Register. 1997; 62(242). Disponible en: http://www.gpo.gov/fdsys/pkg/FR-1997-12- 17/pdf/97-32877.pdf

  16. Centro de Inmunología Molecular. Departamento de Inmunofarmacología. Aspectos Importantes de BPC. Grupo de BPC. La Habana: Centro de Inmunología Molecular; 2003.

  17. Laporte JR. Principios básicos de investigación clínica. Barcelona: Fundació Institut Catalá de Farmacología; 2007. Disponible en: http://www.icf.uab.es/llibre/pdf/Pbic.pdf

  18. Fernández Pita S. Tipos de estudios clínico epidemiológicos. Disponible en: http://www.fisterra.com/mbe/investiga/6tipos_estudios/6tipos_estudios2.pdf

  19. Penchaszadeh VB. Ética de las investigaciones biomédicas en poblaciones humanas. Rev Cubana Salud Pública. 2002; 28(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662002000200005




2020     |     www.medigraphic.com